Skip to main content
All lobbying clients

VERTEX PHARMACEUTICALS

Lobbying client · Massachusetts · filed 2025 to 2026

Global biotechnology company.

$400,000 Reported spend
6 Filings counted
1 Firms hired
7 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (127178), not by name.

 Firms hired 1
 Bills named in these filings 7
  • HR 1227
    Alternatives to PAIN Act
    5 filings
  • S 475
    Alternatives to PAIN Act
    5 filings
  • HR 1518
    New Era of Preventing End-Stage Kidney Disease Act
    2 filings
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…
    2 filings
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
    2 filings
  • HR 7142
    Alternatives to PAIN Act
    1 filing
  • S 3832
    Alternatives to PAIN Act
    1 filing
 Reported by year 2 years
  • 2026 $120,000 2 filings
  • 2025 $280,000 4 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • Executive Office of the President (EOP) 4

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem